Abstract
Background: Increased plasma concentrations of natriuretic peptides have been demonstrated to be associated with increased intracardiac pressure and left ventricular (LV) hypertrophy. After aortic valve replacement (AVR) in aortic stenosis patients, there is a relief of the left outflow obstruction with a substantial hemodynamic improvement. This is followed by a gradual regression of the LV hypertrophy.
Hypothesis: After AVR, reduction in LV filling pressure is expected to occur rapidly, while regression of LV hypertrophy will take place over a longer time period. On this basis we hypothesized that the plasma levels of N‐terminal proatrial natriuretic peptide (NT‐proANP) would be reduced early in the postoperative period, while N‐terminal probrain natriuretic peptide (NT‐proBNP), through its closer reflection of LV hypertrophy, would be sustained for a longer period.
Methods: Two groups of patients with aortic stenosis undergoing AVR were followed for 4 and 12 months, respectively. Plasma concentrations of NT‐pro ANP and NT‐proBNP were measured before and after AVR and related to preoperative findings and changes in the aortic valve area index.
Results: Before AVR, the patients had significantly increased plasma levels of NT‐pro ANP and NT‐proBNP. After AVR, NT‐ pro ANP was decreased at 4 and 12 months but remained elevated compared with controls. N‐terminal‐proBNP tended to decrease, but did not change significantly. When the patients were followed for 12 months, only those with elevated preoperative pulmonary capillary wedge pressure had decreased peptide levels (NT‐proANP: p = 0.017, NT‐proBNP: p = 0.058). There was no regression of LV hypertrophy. The patients with the largest postoperative valve area index [1.27 (1.10‐1.55) cm2/m2] had the largest reduction of NT‐proBNP (47%). Those with the smallest valve area index [0.67 (0.54‐0.73) cm2/m2] had no decrease in NT‐proBNP.
Conclusions: Our study suggests that a reduction in left atrial pressure is the main factor causing the change of NT‐proANP level after AVR. A small prosthetic valve orifice area with a high aortic valve gradient might prevent regression of LV hypertrophy, thus representing a stimulus for increased cardiac secretion of NT‐proBNP.
Keywords: aortic stenosis, aortic valve area, atrial natriuretic factor, atrial pressure, brain natriuretic peptide, left ventricular hypertrophy
Full Text
The Full Text of this article is available as a PDF (94.8 KB).
References
- 1. Raine AE, Erne P, Burgisser E, Muller FB, Bolli P, Burkart F, Buhler FR: Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315: 533–537 [DOI] [PubMed] [Google Scholar]
- 2. Tamamori M, Ito H, Hiroe M, Marumo F, Hata RI: Stimulation of collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic culture conditions and suppression of the effect by natriuretic peptides. Cell Biol Int 1997; 21: 175–180 [DOI] [PubMed] [Google Scholar]
- 3. Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, Kurihara N, Takeda T: Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1‐yearan‐tihypertensive therapy with angiotensin‐converting enzyme inhibitor. Am J Med 1995; 98: 257–265 [DOI] [PubMed] [Google Scholar]
- 4. Thibault G, Murthy KK, Gutkowska J, Seidah NG, Lazure C, Chretien M, Cantin M: NH2‐terminal fragment of rat pro‐atrial natriuretic factor in the circulation: Identification, radioimmunoassay and half‐life. Peptides 1988; 9: 47–53 [DOI] [PubMed] [Google Scholar]
- 5. Hall C, Aaberge L, Stokke O: In vitro stability of N‐terminal proatrial natriuretic factor in unfrozen samples: An important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine (letter). Circulation 1995; 91: 911 [PubMed] [Google Scholar]
- 6. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, Smyth DW: Plasma N‐terminal pro‐brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921–1929 [DOI] [PubMed] [Google Scholar]
- 7. Braunwald E: Aortic stenosis In Heart Disease: A Textbook of Cardiovascular Medicine. 5th Ed., p. 1035–1045. Philadelphia: W. B. Saunders, 1997. [Google Scholar]
- 8. Qi W, Mathisen P, Simonsen S, Bjørnerheim R, Endresen K, Kjekshus J, Hall C: Brain natriuretic peptide in patients with aortic stenosis: Comparison with N‐terminal proatrial natriuretic peptide and atrial natriuretic peptide. Eur Heart J 1998; 19 (suppl): 409 [Google Scholar]
- 9. Ihlen H, Molstad P: Cardiac output measured by Doppler echocardiography in patients with aortic prosthetic valves. Eur Heart J 1990; 11: 399–402 [DOI] [PubMed] [Google Scholar]
- 10. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618 [DOI] [PubMed] [Google Scholar]
- 11. Sundsfjord JA, Thibault G, Larochelle P, Cantin M: Identification and plasma concentrations of the N‐terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605–610 [DOI] [PubMed] [Google Scholar]
- 12. Hollister AS, Rodeheffer RJ, White FJ, Potts JR, Imada T, Inagami T: Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest 1989; 83: 623–628 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Marumo F, Matsubara O, Masaki Y, Togashi K, Ando K, Hasegawa N: Degradation and distribution of brain natriuretic peptide in porcine tissues. J Endocrinol 1992; 132: 101–106 [DOI] [PubMed] [Google Scholar]
- 14. Rademaker MT, Charles CJ, Kosoglou T, Protter AA, Espiner EA, Nicholls MG, Richards AM: Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure. Am J Physiol 1997; 273: 2372–2379 [DOI] [PubMed] [Google Scholar]
- 15. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA: Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐ PROBNP): A new marker of cardiac impairment. Clin Endocrinol 1997; 47: 287–296 [DOI] [PubMed] [Google Scholar]
- 16. Obata K, Yasue H, Okumura K, Matsuyama K, Ogawa H, Kurose M, Saito Y, Nakao K, Imura H, Nobuyoshi M: Atrial natriuretic polypeptide is removed by the lungs and released into the left atrium as well as the right atrium in humans. J Am Coll Cardiol 1990; 15: 1537–1543 [DOI] [PubMed] [Google Scholar]
- 17. Northridge DB, Jamieson MP, Jardine AG, MacArthur KJ, MacFarlane N, Dargie HJ: Pulmonary extraction and left atrial secretion of atrial natriuretic factor during cardiopulmonary bypass surgery. Am Heart J 1992; 123: 698–703 [DOI] [PubMed] [Google Scholar]
- 18. Sutton M, Plappert T, Spiegel A, Raichlen J, Douglas P, Reichek N, Edmunds L: Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: A prospective two‐dimensional echocardiographic study. Circulation 1987; 76: 77–89 [DOI] [PubMed] [Google Scholar]
- 19. Monrad ES, Hess OM, Murakami T, Nonogi H, Corin WJ, Krayenbuehl HP: Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation 1988; 77: 1345–1355 [DOI] [PubMed] [Google Scholar]
- 20. Jin XY, Zhang ZM, Gibson DG, Yacoub MH, Pepper JR: Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg 1996; 62: 683–690 [DOI] [PubMed] [Google Scholar]
- 21. Kuhl H, Puschmann D, Hoffmann R, Schondube F, Franke A, Hanrath P: Regression of left ventricular mass one year after valve replacement for severe aortic stenosis is dependent on prosthetic valve size: A three‐dimensional echocardiographic study. J Am Coll Cardiol 2000; 35 (suppl A): 442A 10676692 [Google Scholar]
- 22. Rahimtoola, SH : The problem of valve prosthesis‐patient mismatch. Circulation 1978; 58: 20–24 [DOI] [PubMed] [Google Scholar]